about
Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols.Improving medication adherence among kidney transplant recipients: Findings from other industries, patient engagement, and behavioral economics-A scoping reviewAccuracy of Continuous Glucose Monitoring in Patients After Total Pancreatectomy with Islet AutotransplantationPortal vein reconstruction in right lobe living-donor liver transplantation.The allocation of livers for transplantation: a problem of Titanic consideration.Effect of changes in surgical practice on the rate and detection of nosocomial infections: a prospective analysis.Preexposure of murine macrophages to CpG-containing oligonucleotides results in nuclear factor kappaB p50 homodimer-associated hyporesponsiveness.Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation.Outcome analysis of intraabdominal infection with resistant gram-positive organisms.Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.Does prior transfusion worsen outcomes from infection in surgical patients?Sex- and diagnosis-dependent differences in mortality and admission cytokine levels among patients admitted for intensive care.Donor morbidity after living donation for liver transplantation.Elderly recipients of hepatitis C positive renal allografts can quickly develop liver diseasePulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosisOutcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantationE2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation.Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"?Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unitIdentification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infectionsLipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosisImpact of immunomodulatory oligodeoxynucleotides on cytokine production in the lipopolysaccharide-stimulated human whole blood model.Ethnic disparities in outcome from posttransplant infections.Chronically inflamed livers up-regulate expression of inhibitory B7 family members.Independent predictors for primary non-function after liver transplantation.Contrast-enhanced MR angiography after pancreas transplantation: normal appearance and vascular complications.Comparison of fungal and nonfungal infections in a broad-based surgical patient population.Magnetic resonance urography for the assessment of potential renal donors: comparison of the RARE technique with a low-dose gadolinium-enhanced magnetic resonance urography technique in the absence of pharmacological and mechanical intervention.Effect of the 80-hour work week on cases performed by general surgery residents.Primary human hepatocytes in spheroid formation to study hepatitis C infection.HCV infection of the transplanted liver: changing CD81 and HVR1 variants immediately after liver transplantation.Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortalityCentral nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings.The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor.Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.Can we define the ideal duration of antibiotic therapy?Cost of Gram-negative resistance.Evaluation of vascular complications of pancreas transplantation with high-spatial-resolution contrast-enhanced MR angiography.
P50
Q24607670-21362D29-3A61-4DEF-A758-01F578D3B8E6Q26770369-67A9629E-E61D-4B3E-BFAA-44DC51D08E0DQ30276933-76A05CE1-8705-4FF5-910C-B7D8C03AA96DQ30308567-2F437C0B-4456-4572-B0F2-FB00995B3186Q30309137-1B883C95-ECF9-4741-BB3B-EE4CA78D0C01Q30309227-4911CC66-5DC8-4955-B132-1F4D4CEA34FFQ30309897-45A7F3C5-ADFC-47F3-84EF-8179984A823BQ30310282-B008FCB2-BD92-428B-A49E-B58A6A9F98F4Q30310542-215F48F9-6844-4DCF-AC70-64EA5A572ED3Q30310749-496CA30B-50C3-4149-B1B7-FEFFBD60206FQ30312219-48432E2E-719F-4948-81DE-98155555C4C4Q30312222-CA271F7F-07E0-4938-BB04-A6448D48AB49Q30339107-7B8F19B0-1CBB-4C26-88A2-66F921DE8E8BQ30417895-EA42C98B-8618-4459-A14E-04673C82B9C7Q30417970-E1C36E94-53C5-430C-9287-51515F32E0E6Q30426015-05E63EC8-41CA-4F49-AF01-274ADA87158BQ30426041-3EB272F8-B6C6-412D-8A6F-51B422CCDB7AQ30431066-04CDA91B-456B-4E83-BD62-26498A0FB1C1Q30432897-B717544A-C584-40B2-8F01-D84ECDC57557Q30432976-31F72B3F-48DB-4FF3-AB40-F601BFEF0A18Q30432979-8063A244-4A44-4FD1-8F8E-CF1F9F2FBD86Q30433267-59798AC7-E2E9-473C-AAE7-F2E36F6A70D8Q30433949-F602F630-9895-476B-A261-6C8CB43E81FEQ30434144-79459E1D-4559-4FDC-B555-42F8C9118DFCQ30434246-3A972312-0267-4F78-AA5F-C72A58D1C2BFQ30434304-1FFD362C-9CA1-4352-B00C-6C1B98773671Q30435531-4969B49F-3A74-4111-A795-3808A7865F15Q30435759-CB41637F-CB61-48CD-8C98-2FF30A84052DQ30436730-A14AC53A-B064-427F-8047-29E6D35E68A5Q30437391-F88F12D1-4E2A-4EFF-94A8-199001CFC850Q30437711-28E874BF-3AA0-4393-9B0E-1AB3340E4E38Q30437996-4D5E58C9-D937-4CDC-BC36-6CCA7A286F1FQ30438047-784FEC87-302B-4796-A794-9FB89AAED261Q30438524-0E48959D-E329-4D79-8373-98D51CEDF187Q30438585-FEDF3355-A6E1-41EB-9093-A58C9DA8E43DQ30440611-A9F7D74B-A74F-4C1D-BF36-0BA1B4AC43CDQ30441628-38B731C8-41E8-4DA2-8EA6-1D779ED81A99Q30442056-A30F4145-CDEA-4120-AF33-033DB507AC79Q30442156-DB919A30-5C78-466A-B8AB-336AE894AD09Q30442736-44A81506-F180-4D27-9C84-A6B1C67961B9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Timothy L Pruett
@ast
Timothy L Pruett
@en
Timothy L Pruett
@es
Timothy L Pruett
@nl
type
label
Timothy L Pruett
@ast
Timothy L Pruett
@en
Timothy L Pruett
@es
Timothy L Pruett
@nl
prefLabel
Timothy L Pruett
@ast
Timothy L Pruett
@en
Timothy L Pruett
@es
Timothy L Pruett
@nl
P106
P31
P496
0000-0002-0715-8535